135 related articles for article (PubMed ID: 3045193)
21. Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.
Gram J; Bollerslev J; Nielsen HK; Junker P
Acta Endocrinol (Copenh); 1991 Dec; 125(6):609-13. PubMed ID: 1789055
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid and type III procollagen peptide in jejunal perfusion fluid as markers of connective tissue turnover.
Colombel JF; Hällgren R; Engström-Laurent A; Rambaud JC
Gastroenterology; 1989 Jan; 96(1):68-73. PubMed ID: 2909439
[TBL] [Abstract][Full Text] [Related]
23. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
24. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease.
Stickel F; Urbaschek R; Schuppan D; Poeschl G; Oesterling C; Conradt C; McCuskey RS; Simanowski UA; Seitz HK
Dig Dis Sci; 2001 Sep; 46(9):2025-32. PubMed ID: 11575459
[TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
von Moers A; Danne T; Möller P; Scheffner D
Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
[TBL] [Abstract][Full Text] [Related]
27. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
28. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of the aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis.
Mattsson L; Lindqvist U; Weiland O; Aberg B
Scand J Infect Dis; 1990; 22(1):11-7. PubMed ID: 2108489
[TBL] [Abstract][Full Text] [Related]
30. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
Remmel T; Remmel H; Salupere V
J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal.
Kropf J; Grobe E; Knoch M; Lammers M; Gressner AM; Lennartz H
Eur J Clin Chem Clin Biochem; 1991 Dec; 29(12):805-12. PubMed ID: 1797106
[TBL] [Abstract][Full Text] [Related]
32. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
33. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of the aminoterminal propeptide of type III procollagen in cultures of human proximal tubular cells.
Jensen LT; Blaehr H; Andersen CB; Risteli J; Lorenzen I
Scand J Clin Lab Invest; 1992 Feb; 52(1):1-8. PubMed ID: 1594884
[TBL] [Abstract][Full Text] [Related]
35. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
[TBL] [Abstract][Full Text] [Related]
36. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
[TBL] [Abstract][Full Text] [Related]
37. Collagen metabolism in normal and complicated pregnancy: changes in the aminoterminal propeptide of type III procollagen in serum.
Risteli L; Puistola U; Hohtari H; Kauppila A; Risteli J
Eur J Clin Invest; 1987 Feb; 17(1):81-6. PubMed ID: 3106054
[TBL] [Abstract][Full Text] [Related]
38. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis.
Savolainen ER; Brocks D; Ala-Kokko L; Kivirikko KI
Biochem J; 1988 Feb; 249(3):753-7. PubMed ID: 3355495
[TBL] [Abstract][Full Text] [Related]
39. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scheja A; Akesson A; Hørslev-Petersen K
Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
